⌘K

Login Start Free

Home/Filings/4/0001209191-18-036184

4//SEC Filing

Scranton Richard 4

Accession 0001209191-18-036184

CIK 0001396814other

View on SEC.gov Company Profile

Filed

Jun 5, 8:00 PM ET

Accepted

Jun 6, 8:09 PM ET

Size

4.9 KB

Accession

0001209191-18-036184

Insider Transaction Report

Form 4

Period: 2018-06-04

Pacira Pharmaceuticals, Inc.PCRX

Scranton Richard

Chief Scientific Officer

Transactions

Sale
Common Stock
2018-06-04$33.02/sh−1,367$45,138→ 12,226 total

Footnotes (1)

[F1]Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Pacira Pharmaceuticals, Inc.

CIK 0001396814

Entity typeother

Related Parties

1

filerCIK 0001709330

Filing Metadata

Form type: 4
Filed: Jun 5, 8:00 PM ET
Accepted: Jun 6, 8:09 PM ET
Size: 4.9 KB

View on SEC.gov